DOI QR코드

DOI QR Code

Parenteral Docetaxel Emulsion System and Its Stability

  • Published : 2009.02.20

Abstract

Docetaxel is an anticancer agent with low aqueous solubility. More extensive clinical use of this drug is somewhat delayed due to lack of appropriate delivery vehicles. An attempt was made to adopt an o/w emulsion as the drug carrier which incorporated docetaxel in the propyleneglycerol stabilized by a mixed-emulsifier system. A suitable formulation was found in this study: 10 mg/mL docetaxel, 10% (w/v) oil blend, 4% (w/v) PG, 3% (w/v) Solutol HS 15 in 2.25% (w/v) glycerol solution. The formulated emulsion has very good stability when stored at $40^{\cird}C$, and the docetaxel containment efficiency can be maintained above 95% and the mean emulsion diameter around $10{\mu}m$ for at least 3 months. The formulated emulsion is a promising carrier for docetaxel and other lipophilic drugs.

Keywords

References

  1. R.M. Strother and C. Sweeney, Lessons learned from development of docetaxel. Expert Opin Drug Metab Toxicol. 4(7), 1007-19 (2008 Jul) https://doi.org/10.1517/17425255.4.7.1007
  2. E. Saloustros and V. Georgoulias, Docetaxel in the treatment of advanced non-small-cell lung cancer. Expert Rev Anticancer Ther. 8(8), 1207-22 (2008). https://doi.org/10.1586/14737140.8.8.1207
  3. V. Gebbia, C. Gridelli, C. Verusio, L. Frontini, E. Aitini, B. Daniele, T. Gamucci, G. Mancuso, M. Di Maio, C. Gallo, F. Perrone and A. Morabito, Weekly docetaxel vs. docetaxelbased combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients The DISTAL-2 randomized trial. Lung Cancer. 2008 Jul 14. [Epub ahead of print]
  4. J.Y. Joung, I.G. Jeong, K.S. Han, T.S. Kim, S.O. Yang, H.K. Seo, J. Chung, K.S. Cho and K.H. Lee, Docetaxel Chemotherapy of Korean Patients with Hormone- refractory Prostate Cancer:Comparative Analysis between 1st-line and 2nd-line Docetaxel.Yonsei Med J., 49(5), 775-82 (2008) https://doi.org/10.3349/ymj.2008.49.5.775
  5. G.H. Yoo, G. Subramanian, M.P. Piechocki, J.F. Ensley, O. Kucuk, O.E. Tulunay, F. Lonardo, H. Kim, J. Won, T. Stevens and H.S. Lin, Effect of docetaxel on the surgical tumor microenvironment of head and neck cancer in murine models. Arch Otolaryngol Head Neck Surg., 134(7), 735-42 (2008) https://doi.org/10.1001/archotol.134.7.735
  6. J. Baker, J. Ajani, F. Scotte, D. Winther, M. Martin, M.S. Aapro and G. von Minckwitz, Docetaxel-related side effects and their management.Eur J Oncol Nurs., 12(3), 253-68 (2008) https://doi.org/10.1016/j.ejon.2008.03.006
  7. L. Chew and V.S. Lee Chuen, Cutaneous reaction associated with weekly docetaxel administration. J Oncol Pharm Pract. 2008 Aug 27. [Epub ahead of print]
  8. J. Vial, M. Cohen, P. Sassiat and D. Thiebaut, Pharmaceutical quality of docetaxel generics versus originator drug product: a comparative analysis. Curr Med Res Opin., 24(7), 2019-33 (2008). PMID: 18544188 [PubMed - indexed for MEDLINE] https://doi.org/10.1185/03007990802207874
  9. H.Y. Hwang, I.S. Kim, I.C. Kwon and Y.H. Kim, Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.J Control Release., 128(1), 23-31 (2008) https://doi.org/10.1016/j.jconrel.2008.02.003
  10. M.V. Lozano, D. Torrecilla, D. Torres, A. Vidal, F. Dominguez, and M.J. Alonso, Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers. Biomacromolecules., 9(8), 2186-93 (2008) https://doi.org/10.1021/bm800298u
  11. B. Liu, M. Yang, R. Li, Y. Ding, X. Qian, L. Yu and X. Jiang, The antitumor effect of novel docetaxel-loaded thermosensitive micelles. Eur J Pharm Biopharm., 69(2), 527-34 (2008) https://doi.org/10.1016/j.ejpb.2008.01.015
  12. J. Chen, L. Qiu, M. Hu, Y. Jin and J. Han, Preparation, characterization and in vitro evaluation of solid dispersions containing docetaxel. Drug Dev Ind Pharm., 34(6), 588-94 (2008) https://doi.org/10.1080/03639040701831835
  13. F. Esmaeili, M.H. Ghahremani, S.N. Ostad, F. Atyabi, M. Seyedabadi, M.R. Malekshahi, M. Amini and R. Dinarvand, Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate. J Drug Target., 16(5), 415-23 (2008) https://doi.org/10.1080/10611860802088630
  14. M. Senthilkumar, P. Mishra and N.K. Jain, Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors. J Drug Target. Jun; 16(5), 424-35 (2008) https://doi.org/10.1080/10611860802088598
  15. S.S. Chandran, S.R. Banerjee, R.C. Mease, M.G. Pomper and S.R. Denmeade, Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA). Cancer Biol Ther. Jun; 7(6), 974-82 (2008) https://doi.org/10.4161/cbt.7.6.5968
  16. Y. Qiu, Y. Gao, K. Hu and F. Li, Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J Control Release., 129(2), 144-50 (2008) https://doi.org/10.1016/j.jconrel.2008.04.019
  17. A. Fernaìndez-Botello, F. Comelles, M.A. Alsina, P. Cea and F. Reig, A Monolayer Study on Interactions of Docetaxel with Model Lipid Membranes. J. Phys Chem B., 112(44), 13834-13841 (2008) https://doi.org/10.1021/jp806423k
  18. Z. Xu, L. Chen, W. Gu, Y. Gao, L. Lin, Z. Zhang, Y. Xi and Y. Li, The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials., 30(2), 226-32 (2009) https://doi.org/10.1016/j.biomaterials.2008.09.014
  19. Y. Gao, L. Chen, W. Gu, Y. Xi, L. Lin and Y. Li, Targeted Nanoassembly Loaded with Docetaxel Improves Intracellular Drug Delivery and Efficacy in Murine Breast Cancer Model. Mol Pharm. 2008 Oct 9. [Epub ahead of print]
  20. F. Esmaeili, R. Dinarvand, M.H. Ghahremani, M. Amini, H. Rouhani, N. Sepehri, S.N. Ostad and F. Atyabi, Docetaxel-albumin conjugates: Preparation, in vitro evaluation and biodistribution studies. J Pharm Sci. 2008 Oct 28. [Epub ahead of print]
  21. K. Gao, J. Sun, K. Liu, X. Liu and Z. He, Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel. Drug Dev Ind Pharm., 34(11), 1227-37 (2008). https://doi.org/10.1080/03639040802005057